Kuros Biosciences AG
SIX:KURN

Watchlist Manager
Kuros Biosciences AG Logo
Kuros Biosciences AG
SIX:KURN
Watchlist
Price: 29.92 CHF -0.13%
Market Cap: 1.1B CHF

Wall Street
Price Targets

KURN Price Targets Summary
Kuros Biosciences AG

Wall Street analysts forecast KURN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KURN is 35.34 CHF with a low forecast of 33.13 CHF and a high forecast of 38.33 CHF.

Lowest
Price Target
33.13 CHF
11% Upside
Average
Price Target
35.34 CHF
18% Upside
Highest
Price Target
38.33 CHF
28% Upside
Kuros Biosciences AG Competitors:
Price Targets
002675
Yantai Dongcheng Biochemicals Co Ltd
23% Upside
RYTM
Rhythm Pharmaceuticals Inc
28% Upside
QTTB
Homology Medicines Inc
257% Upside
ZEAL
Zealand Pharma A/S
51% Upside
EXAS
Exact Sciences Corp
1% Downside
PRQR
ProQR Therapeutics NV
329% Upside
301207
Hualan Biological Bacterin Inc
7% Downside
ORGO
Organogenesis Holdings Inc
86% Upside

Revenue
Forecast

Revenue Estimate
Kuros Biosciences AG

For the last 13 years the compound annual growth rate for Kuros Biosciences AG's revenue is 37%. The projected CAGR for the next 3 years is 39%.

37%
Past Growth
39%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Kuros Biosciences AG

The compound annual growth rate of Kuros Biosciences AG's operating income for the next 3 years is 523%.

N/A
Past Growth
523%
Estimated Growth
Estimates Accuracy
33%
Average Beat

Net Income
Forecast

Net Income Estimate
Kuros Biosciences AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KURN's stock price target?
Price Target
35.34 CHF

According to Wall Street analysts, the average 1-year price target for KURN is 35.34 CHF with a low forecast of 33.13 CHF and a high forecast of 38.33 CHF.

What is Kuros Biosciences AG's Revenue forecast?
Projected CAGR
39%

For the last 13 years the compound annual growth rate for Kuros Biosciences AG's revenue is 37%. The projected CAGR for the next 3 years is 39%.

What is Kuros Biosciences AG's Operating Income forecast?
Projected CAGR
523%

The compound annual growth rate of Kuros Biosciences AG's operating income for the next 3 years is 523%.

Back to Top